1. Behera DK, Behera PM, Acharya L, Dixit A, Padhi P.
In silico biology of H1N1: molecular modelling of novel receptors and docking studies of inhibitors to reveal new insight in flu treatment. J Biomed Biotechnol 2012;2012:714623. PMID:
23125526.
2. Gallaher WR. Towards a sane and rational approach to management of Influenza H1N1 2009. Virol J 2009;6:51. PMID:
19422701.
3. Harrison SC. Viral membrane fusion. Nat Struct Mol Biol 2008;15:690–698. PMID:
18596815.
4. Burmeister WP, Ruigrok RW, Cusack S. The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid. EMBO J 1992;11:49–56. PMID:
1740114.
5. Eiland LS, Eiland EH. Zanamivir for the prevention of influenza in adults and children age 5 years and older. Ther Clin Risk Manag 2007;3:461–465. PMID:
18488077.
6. Heinonen S, Silvennoinen H, Lehtinen P, Vainionpää R, Vahlberg T, Ziegler T,
et al. Early oseltamivir treatment of influenza in children 1-3 years of age: a randomized controlled trial. Clin Infect Dis 2010;51:887–894. PMID:
20815736.
7. Narayanan MM, Nair CB, Sanjeeva SK, Rao PS, Pullela PK, Barrow CJ. Design of multiligand inhibitors for the swine flu H1N1 neuraminidase binding site. Adv Appl Bioinform Chem 2013;6:47–53. PMID:
23983477.
8. Arora R, Singh S, Sharma RK. Neem leaves: Indian herval medicine. (Watson RR, Preedy VR, eds.). In: Botanical Medicine in Clinical Practice Wallingford: CABI, 2008. pp. 85–98.
9. Chatterjee A, Saha SK. Isolation of allo-imperatorin and β-sitosterol from the fruits of Aegle marmelos Correa. J Indian Chem Soc 1957;34:228–230.
11. Shah A, Krishnamurthy R. Swine flu and its herbal remedies. Int J Eng Sci 2013;2:68–78.
12. Chopra RN, Nayar SL, Chopra IC. Glossary of Indian Medicinal Plants. New Delhi: Council of Scientific & Industrial Research, 1956.
13. Hornung B, Amtmann E, Sauer G. Lauric acid inhibits the maturation of vesicular stomatitis virus. J Gen Virol 1994;75(Pt 2):353–361. PMID:
8113756.
14. Wolkerstorfer A, Kurz H, Bachhofner N, Szolar OH. Glycyrrhizin inhibits influenza A virus uptake into the cell. Antiviral Res 2009;83:171–178. PMID:
19416738.
15. Winston D, Maimes S. Adaptogens: Herbs for Strength, Stamina, and Stress Relief. Rochester: Healing Arts Press, 2007.
16. Bown D. Encyclopedia of Herbs and Their Uses. London: Dorling Kindersley, 1995.
17. Naik GH, Priyadarsini KI, Naik DB, Gangabhagirathi R, Mohan H. Studies on the aqueous extract of Terminalia chebula as a potent antioxidant and a probable radioprotector. Phytomedicine 2004;11:530–538. PMID:
15500265.
18. Yiannakopoulou EC. Recent patents on antibacterial, antifungal and antiviral properties of tea. Recent Pat Antiinfect Drug Discov 2012;7:60–65. PMID:
22353001.
19. Kelley LA, Sternberg MJ. Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 2009;4:363–371. PMID:
19247286.
20. Krieger E, Joo K, Lee J, Lee J, Raman S, Thompson J,
et al. Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8. Proteins 2009;77(Suppl 9):114–122. PMID:
19768677.
21. Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst 1993;26:283–291.
22. Wiederstein M, Sippl MJ. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 2007;35:W407–W410. PMID:
17517781.
23. Wallner B, Elofsson A. Can correct protein models be identified? Protein Sci 2003;12:1073–1086. PMID:
12717029.
24. Colovos C, Yeates TO. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci 1993;2:1511–1519. PMID:
8401235.
25. Wang Y, Xiao J, Suzek TO, Zhang J, Wang J, Bryant SH. PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res 2009;37:W623–W633. PMID:
19498078.
26. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS,
et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 2009;30:2785–2791. PMID:
19399780.
27. Kumar S, Jena L, Galande S, Daf S, Mohod K, Varma AK. Elucidating molecular interactions of natural inhibitors with HPV-16 E6 oncoprotein through docking analysis. Genomics Inform 2014;12:64–70. PMID:
25031569.
28. Jagadeb M, Konkimalla VB, Rath SN, Das RP. Elucidation of the inhibitory effect of phytochemicals with Kir6.2 wild-type and mutant models associated in Type-1 diabetes through molecular docking approach. Genomics Inform 2014;12:283–288. PMID:
25705171.
29. Wallace AC, Laskowski RA, Thornton JM. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 1995;8:127–134. PMID:
7630882.
30. Russell RJ, Haire LF, Stevens DJ, Collins PJ, Lin YP, Blackburn GM,
et al. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 2006;443:45–49. PMID:
16915235.
31. van der Vries E, Collins PJ, Vachieri SG, Xiong X, Liu J, Walker PA,
et al. H1N1 2009 pandemic influenza virus: resistance of the I223R neuraminidase mutant explained by kinetic and structural analysis. PLoS Pathog 2012;8:e1002914. PMID:
23028314.
32. Ramachandran M, Nambikkairaj B, Bakyavathy M.
In silico molecular modeling of neuraminidase enzyme H1N1 avian influenza virus and docking with zanamivir ligands. Asian Pac J Trop Dis 2012;2:426–430.
33. Gupta S, Saxena V, Singh B. Homology modeling and docking studies of neuraminidase protein of influenza A virus (H1N1) virus with select ligand: a computer aided structure based drug design. Int J Pharm Sci Invent 2013;2:35–41.